Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.

Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT.

Neurology. 1998 Jan;50(1):136-45.

PMID:
9443470
2.

Perspectives in the management of Alzheimer's disease: clinical profile of donepezil.

Rogers SL.

Dement Geriatr Cogn Disord. 1998;9 Suppl 3:29-42. Review.

PMID:
9853200
3.

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials.

Whitehead A, Perdomo C, Pratt RD, Birks J, Wilcock GK, Evans JG.

Int J Geriatr Psychiatry. 2004 Jul;19(7):624-33. Review.

PMID:
15254918
4.

Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness.

Wolfson C, Oremus M, Shukla V, Momoli F, Demers L, Perrault A, Moride Y.

Clin Ther. 2002 Jun;24(6):862-86; discussion 837. Review.

PMID:
12117079
5.

Donepezil for vascular cognitive impairment.

Malouf R, Birks J.

Cochrane Database Syst Rev. 2004;(1):CD004395. Review.

PMID:
14974068
6.

Donepezil: in vascular dementia.

Goldsmith DR, Scott LJ.

Drugs Aging. 2003;20(15):1127-36. Review.

PMID:
14651435
7.

Donepezil: a review of its use in Alzheimer's disease.

Dooley M, Lamb HM.

Drugs Aging. 2000 Mar;16(3):199-226. Review.

PMID:
10803860
8.

Donepezil for dementia due to Alzheimer's disease.

Birks J, Harvey RJ.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001190. Review.

PMID:
16437430
9.

Donepezil for mild and moderate Alzheimer's disease.

Birks J S, Melzer D.

Cochrane Database Syst Rev. 2000;(2):CD001190. Review. Update in: Cochrane Database Syst Rev. 2000;(4):CD001190.

PMID:
10796620
10.

Donepezil for dementia due to Alzheimer's disease.

Birks JS, Harvey R.

Cochrane Database Syst Rev. 2003;(3):CD001190. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD001190.

PMID:
12917900
11.

Donepezil for mild and moderate Alzheimer's disease.

Birks JS, Melzer D, Beppu H.

Cochrane Database Syst Rev. 2000;(4):CD001190. Review. Update in: Cochrane Database Syst Rev. 2003;(3):CD001190.

PMID:
11034704
12.

Donepezil.

Bryson HM, Benfield P.

Drugs Aging. 1997 Mar;10(3):234-9; discussion 240-1. Review.

PMID:
9108896
13.

Donepezil for mild cognitive impairment.

Birks J, Flicker L.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006104. Review.

PMID:
16856114
14.

Donepezil: an anticholinesterase inhibitor for Alzheimer's disease.

Shintani EY, Uchida KM.

Am J Health Syst Pharm. 1997 Dec 15;54(24):2805-10. Review.

PMID:
9428950
15.

Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence.

Lockhart IA, Mitchell SA, Kelly S.

Dement Geriatr Cogn Disord. 2009;28(5):389-403. doi: 10.1159/000255578. Epub 2009 Nov 6. Review.

16.

Reviews: Effects of transdermal rivastigmine on ADAS-cog items in mild-to-moderate Alzheimer's disease.

Grossberg GT, Schmitt FA, Meng X, Tekin S, Olin J.

Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):627-33. doi: 10.1177/1533317510385808. Review.

PMID:
21131668
17.

The safety and tolerability of donepezil in patients with Alzheimer's disease.

Jackson S, Ham RJ, Wilkinson D.

Br J Clin Pharmacol. 2004 Nov;58 Suppl 1:1-8. Review.

18.

Donepezil across the spectrum of Alzheimer's disease: dose optimization and clinical relevance.

Lee JH, Jeong SK, Kim BC, Park KW, Dash A.

Acta Neurol Scand. 2015 May;131(5):259-67. doi: 10.1111/ane.12386. Epub 2015 Feb 18. Review.

PMID:
25690270
19.

High-dose donepezil (23 mg/day) for the treatment of moderate and severe Alzheimer's disease: drug profile and clinical guidelines.

Cummings JL, Geldmacher D, Farlow M, Sabbagh M, Christensen D, Betz P.

CNS Neurosci Ther. 2013 May;19(5):294-301. doi: 10.1111/cns.12076. Epub 2013 Mar 6. Review.

PMID:
23462265
20.

Statin therapy in Alzheimer's disease.

Sparks DL, Sabbagh M, Connor D, Soares H, Lopez J, Stankovic G, Johnson-Traver S, Ziolkowski C, Browne P.

Acta Neurol Scand Suppl. 2006;185:78-86. Review.

PMID:
16866915
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk